Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
Bajaj Hindusthan to sell Lalitpur Power stake

2018-07-12 freepressjournal.in
New Delhi : Bajaj Hindusthan Sugar plans to sell its entire 17.51 per cent stake in the group firm Lalitpur Power Generation Company (LPGCL), estimated to be worth Rs 1,100 crore.
BAJAJHIND 500032

0
Bajaj Hindusthan to sell 17.51% stake in group#39;s power firm LPGCL

2018-07-11 moneycontrol
Bajaj Hindusthan Sugar plans to sell its entire 17.51 percent stake in the group firm Lalitpur Power Generation Company Ltd (LPGCL), estimated to be worth Rs 1,100 crore. The company had invested Rs 770 crore in LPGCL and now needs to divest non-core assets as per the debt restructuring scheme approved by the lenders.
BAJAJHIND 500032

0
Bajaj Hindusthan Sugar Limited - Clarification

2018-07-08 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
BAJAJHIND 500032

0
Bajaj Hindusthan Sugar board okays share sale in Lalitpur Power

2018-07-06 thehindubusinessline
The board of directors of Bajaj Hindusthan Sugar on Friday approved a proposal for convening an Extraordinary General Meeting to consider ordinary and special resolutions for sale and transfer of 1,54,39,900 equity shares of ₹10 each held by the company in Lalitpur Power Generation Company to Bajaj Energy, a related party of the company. Shares of Bajaj Hindusthan ended flat at ₹6.50 on the NSE.
BAJAJHIND 500032

0
Bajaj Hindusthan Sugar Limited - Outcome of Board Meeting

2018-07-06 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
BAJAJHIND 500032

2
Sugar stocks ‘sweeten’ on govt bailout package

2018-06-06 thehindubusinessline
Shares of sugar producers climbed in the afternoon trade as the Union Cabinet has approved a Rs 8,500-crore bailout package for the sugar industry which includes Rs 4,500-crore soft loan for building ethanol production capacity and creating a 3-million-tonne stockpile to soak up excess supply.
BAJAJHIND 530363 UGARSUGAR NDAQ IDFCBANK DCMSHRIRAM 500032 523367 539437

0
Sugar stocks ‘sweeten’ on reports of bailout package

2018-06-05 thehindubusinessline
Sugar stocks rose up to 7 per cent today amid reports that the government is likely to announce a bailout package of over Rs 7,000 crore to ensure cash-starved mills clear dues to farmers at the earliest.
BAJAJHIND MAWANASUG BALRAMCHIN 523371 UTTAMSUGAR 532729 500119 500038 500032 DHAMPURSUG

0
Fire at Bajaj Hindusthan's Kinauni sugar mill

2018-05-28 thehindubusinessline
In another incident of fire, sugar major Bajaj Hindusthan Sugar has said that in the afternoon of Saturday, May 26, a fire broke out in one of the storage tanks of the company’s distillery division at Kinauni, Meerut, Uttar Pradesh, during loading of ethanol in containers.
BAJAJHIND 500032

0
Bajaj Hindusthan Sugar Limited - Updates

2018-05-28 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
BAJAJHIND 500032

0
Bajaj Hindusthan Sugar posts Q4 loss at Rs158 crore

2018-05-27 livemint
New Delhi: Bajaj Hindusthan Sugar on Saturday reported a net loss of Rs157.77 crore in the March quarter of 2017-18. In the January-March period of the preceding financial year, its had a net profit of Rs 259.13 crore.
BAJAJHIND 500032

0
Bajaj Hindusthan Sugar Limited - Board Meeting Postponed

2018-05-11 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
BAJAJHIND 500032

3
High-debt cos’ scrips suffer in Q1 of 2018

2018-04-13 thehindubusinessline
The first quarter of calendar year 2018 has not been too good for Indian investors, with benchmark indices reversing sharply in February.
BAJAJHIND BALRAMCHIN 534690 BHUSANSTL HIN 532712 514034 PNJZY RCOM 532461 LAKSHVILAS JBFIND PNB 500038 500185 500032 500055 HCC

10
Sugar stocks ‘sweeten’ as govt plans to pay Rs 55/t to cane farmers

2018-04-10 thehindubusinessline
The government plans to pay Rs 55 a tonne to cane farmers, while mills would pay the rest of the state-set price.
AXBKY BAJAJHIND BALRAMCHIN AXBA AXB AXISBANK 500119 500038 500032 532215 DHAMPURSUG

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

9h - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

11h - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...